Why the study?
The extent and significance of cardiac remodeling in Fontan patients were unclear.
Are cardiovascular magnetic resonance imaging markers of cardiac function, myocardial fibrosis, and hemodynamics associated with adverse outcomes in young Fontan patients?
Are cardiovascular magnetic resonance imaging markers of cardiac function, myocardial fibrosis, and hemodynamics associated with adverse outcomes in young Fontan patients?
In pediatric Fontan patients, increased aortopulmonary collateral flow and adverse fibrotic remodeling on CMR are associated with poor clinical outcomes.
Answers are grounded in this paper and cite their sources.
APC flow on CMR may refine risk stratification in Fontan patients; leaves open whether targeting collaterals improves outcomes.
BACKGROUND: The extent and significance in of cardiac remodeling in Fontan patients are unclear and were the subject of this study. METHODS: This retrospective cohort study compared cardiovascular magnetic resonance (CMR) imaging markers of cardiac function, myocardial fibrosis, and hemodynamics in young Fontan patients to controls. APC flow (HR 5.5 CI 1.9-16.2, p = 0.002) was independently associated with the composite outcome, independent of ventricular morphology (HR 0.71 CI 0.30-1.69 p = 0.44) and T1 (HR1.006 CI 1.0-1.13, p = 0.07). CONCLUSIONS: Pediatric Fontan patients have ventricular dysfunction, altered myocardial mechanics and increased fibrotic remodeling. Cumulative exposure to cardiopulmonary bypass and increased aortopulmonary collateral flow are associated with myocardial dysfunction and fibrosis. Cardiac dysfunction, fibrosis, and collateral flow are associated with adverse outcomes.
No takes yet. Share an insight, caveat, or question.
Pisesky et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: